LivingGLP1
Study S000974

Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes

Registration

Registration
NCT01856790
Study type
INTERVENTIONAL
Phase
EARLY_PHASE1
Masking
NONE
Status
COMPLETED
Enrollment
15
Start
2013-02
Primary completion
2015-11
Lead sponsor
Jennifer Sherr
Conditions
Type 1 Diabetes
Interventions
DEVICE:ePID closed loop system; DRUG:liraglutide
Results posted
TRUE

Registered primary outcomes

  • Peak Post-prandial Venous Glucose Levels [48 hours]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.